Skip to main content
Premium Trial:

Request an Annual Quote

Burnham Institute Buys Labcyte's Liquid Handlers for Fla., Calif. Labs

NEW YORK (GenomeWeb News) – The Burnham Institute for Medical Research will use Labcyte’s Echo liquid handlers in two of its laboratories for research in cancer, neurological diseases, aging, diabetes, and obesity, Labcyte said this week.
 
Labcyte said the agreement is worth $2.3 million and that the systems will be delivered in about six months.
 
Burnham will use the liquid handlers in facilities in La Jolla, Calif., and Lake Nona, Fla., as part of the National Institutes of Health’s Molecular Libraries Screening Centers Network. The institute is one of 10 screening centers under the NIH Roadmap initiative.
 
The institute will use the Echo systems for compound plate-to-plate transfer, reformatting, dose-response experiments, and hit picking.
 
Financial terms of the agreement were not released.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.